Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-005814
Filing Date
2025-01-14
Accepted
2025-01-14 08:40:53
Documents
6
Period of Report
2025-01-14

Document Format Files

Seq Description Document Type Size
1 6-K d914171d6k.htm 6-K 10015
2 EX-99.1 d914171dex991.htm EX-99.1 24772
3 EX-99.2 d914171dex992.htm EX-99.2 24269
4 GRAPHIC g914171g0114041955805.jpg GRAPHIC 2601
5 GRAPHIC g914171g0114042221412.jpg GRAPHIC 2601
6 GRAPHIC g914171g0114073535889.jpg GRAPHIC 1087
  Complete submission text file 0001193125-25-005814.txt   69407
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 25527849
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)